.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Matthias Eiber

Munich / DE

Technische Universität München

Vortrag

12.09.2024
14:20 – 14:40 15 Min. 5 Min.
Talk
JS02.02
Radiotheranostics in oncology: Current challenges and emerging opportunities (EANM)

Weitere Beteiligungen

13.09.2024
14:24 – 14:28 3 Min. 1 Min.
Eposter presentation
PP25.09
Patlak parameters for whole body PET – Analysis of reconstruction stability
Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
13.09.2024
14:39 – 14:43 3 Min. 1 Min.
Eposter presentation
PP33.09
Investigation of the I-131 contamination risk after radioiodine therapy in patient rooms
Diagnostic and therapeutic nuclear medicine, Radiation protection
13.09.2024
14:40 – 14:44 3 Min. 1 Min.
Eposter presentation
PP16.15
A PSMA PET/MR regression model to reduce unnecessary biopsies
Artificial intelligence, Diagnostic and therapeutic nuclear medicine